Surrozen, Inc. Common

SRZNNASDAQUSD
19.00 USD
0.45 (2.31%)AT CLOSE (11:59 AM EDT)
18.97
0.03 (0.16%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
18.97
0.03 (0.16%)
🔴Market: CLOSED

SRZN is currently priced at $19.00. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 2/9, exceptional Return on Equity (160.2%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation front, SRZN trades at elevated multiples relative to its peers, earning a "Richly Valued" assessment.

Technical & fundamental data as of Sep 11, 2026.

Open?$19.68
High?$19.72
Low?$18.71
Prev. Close?$19.45
Volume?145.3K
Avg. Volume?214.1K
VWAP?$19.03
Rel. Volume?0.68x
Bid / Ask
Bid?$15.87 × 100
Ask?$23.06 × 100
Spread?$7.19
Midpoint?$19.47
Valuation & Ratios
Market Cap?223.3M
Shares Out?11.6M
Float?4.1M
Float %?47.9%
P/E Ratio?N/A
P/B Ratio?-1.02
EPS?-$29.80
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-8141(for wet AMD, DME), SZN-413( For retinopathies) and SZN-8143 (for wet AMD, DME, UME).
Employees
44
Market Cap
223.3M
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed
2021-08-12
Address
171 OYSTER POINT BLVD
SOUTH SAN FRANCISCO, CA 94080
Phone: 650-475-2820
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)? Bearish(-3/3)
Medium-Term (Wave)? Bearish(-2/3)
Short-Term (Ripple)? Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
12
Z-Score?
0
Momentum?
50
Short Sent.?
26
Piotroski F-Score?2/9Weak
Altman Z-Score?-7.05Distress
Confidence?58%Low
Full Fundamental Analysis →
Short InterestSqueeze Risk
Short % of Float?35.21%Squeeze Risk
Short Interest?1.4M
Days to Cover?7.7
Free Float4.1M
Avg Daily Volume187.1K
Settlement Date2026-08-31
Financial Health
Current Ratio?12.14Strong
Quick Ratio?12.14Strong
Cash Ratio?11.32Strong
Debt/Equity?-0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A
P/B?
S&P
97
-1.02CHEAP
P/S?
Peers
100
S&P
3
19.40HIGH
P/FCF?
N/A
EV/EBITDA?
S&P
97
-2.8CHEAP
EV/Sales?
Peers
100
S&P
10
10.54HIGH
Returns & Efficiency
ROE?
Peers
50
S&P
97
160.2%STRONG
ROA?
S&P
3
-303.0%WEAK
Cash Flow & Enterprise
FCF?$-34984000
Enterprise Value?$121.3M
Fundamentals ratios updated end of day